These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2837141)

  • 1. Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.
    Robillard NJ; Scarpa AL
    Antimicrob Agents Chemother; 1988 Apr; 32(4):535-9. PubMed ID: 2837141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of action of and resistance to ciprofloxacin.
    Hooper DC; Wolfson JS; Ng EY; Swartz MN
    Am J Med; 1987 Apr; 82(4A):12-20. PubMed ID: 3034057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa.
    Masecar BL; Celesk RA; Robillard NJ
    Antimicrob Agents Chemother; 1990 Feb; 34(2):281-6. PubMed ID: 2158277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.
    Celesk RA; Robillard NJ
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1921-6. PubMed ID: 2514623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.
    Rella M; Haas D
    Antimicrob Agents Chemother; 1982 Aug; 22(2):242-9. PubMed ID: 6821455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
    Grimm H
    Arzneimittelforschung; 1985; 35(3):570-2. PubMed ID: 2986655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.
    Masecar BL; Robillard NJ
    Antimicrob Agents Chemother; 1991 May; 35(5):898-902. PubMed ID: 1649573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-host-range gyrase A gene probe.
    Robillard NJ
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1889-94. PubMed ID: 1963286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant.
    Inoue Y; Sato K; Fujii T; Hirai K; Inoue M; Iyobe S; Mitsuhashi S
    J Bacteriol; 1987 May; 169(5):2322-5. PubMed ID: 3032915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorhexidine hypersensitivity of ciprofloxacin-resistant variants of Pseudomonas aeruginosa PAO.
    Baillie LW; Power EG; Phillips I
    J Antimicrob Chemother; 1993 Feb; 31(2):219-25. PubMed ID: 8385092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem.
    Cambau E; Perani E; Dib C; Petinon C; Trias J; Jarlier V
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2248-52. PubMed ID: 8619577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
    Kocagöz T; Hackbarth CJ; Unsal I; Rosenberg EY; Nikaido H; Chambers HF
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1768-74. PubMed ID: 8843279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of high-level quinolone resistance in Campylobacter jejuni.
    Gootz TD; Martin BA
    Antimicrob Agents Chemother; 1991 May; 35(5):840-5. PubMed ID: 1649570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ofloxacin resistance mechanism in PA150 and PA300-clinical isolates of Pseudomonas aeruginosa in Korea.
    Lee S; Lee Y
    Arch Pharm Res; 1998 Dec; 21(6):671-6. PubMed ID: 9868535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ofloxacin-resistant Pseudomonas aeruginosa mutants with elevated drug extrusion across the inner membrane.
    Lei Y; Sato K; Nakae T
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1043-8. PubMed ID: 1651710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.
    Ng EY; Trucksis M; Hooper DC
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1881-8. PubMed ID: 8843298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA gyrase (Topoisomerase II) from Pseudomonas aeruginosa.
    Miller RV; Scurlock TR
    Biochem Biophys Res Commun; 1983 Jan; 110(2):694-700. PubMed ID: 6301461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of Citrobacter freundii DNA gyrase and inhibition by quinolones.
    Aoyama H; Sato K; Fujii T; Fujimaki K; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1988 Jan; 32(1):104-9. PubMed ID: 2831810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.